Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) (REWIND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01394952
Recruitment Status : Completed
First Posted : July 15, 2011
Last Update Posted : September 14, 2018
Information provided by (Responsible Party):
Eli Lilly and Company